Palobiofarma announces the completion the Phase II clinical trial with its investigational therapy PBF-680 in chronic obstructive pulmonary disease (COPD) patients

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visit” of the Phase II trial investigating the safety and preliminary efficacy of PBF-680 in moderate to severe COPD patients.

Read more

Laminar Pharma opens a new seek capital round of up to seven million euros

by Laminar Pharma

Laminar Pharma opens a new financing round of up to seven million euros. The objective is to finish financing the development of its drug LAM561 against the most aggressive and common brain cancer, gl...

Read more

INCLIVA evalúa la seguridad y tolerabilidad de blinatumomab administrado de forma subcutánea en el tratamiento de leucemia linfoblástica aguda en adultos

by INCLIVA

El Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico Universitario de València, ha impulsado un ensayo clínico para evaluar la seguridad y la tolerabilidad del anticuerpo blinatum...

Read more

Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens

by Theriva™ Biologics

Theriva™ Biologics has announced the presentation of preclinical data demonstrating enhanced anti-tumor effects in human pancreatic cancer xenograft-bearing mice treated with lead product candidate...

Read more

Un estudio preclínico mejora el tratamiento de los tumores cerebrales pediátricos más agresivos

by CIMA - Centro de Investigación Médica Aplicada

Investigadores del Cima Universidad de Navarra constatan que la combinación de dos fármacos, ya conocidos, abre el camino a posibles ensayos clínicos para combatir los gliomas difusos de línea med...

Read more

The Future of Pharmaceutical Innovation

by Laboratorios Rubió, S.A.

This article explores the current state of pharmaceutical innovation, predicts future trends, and discusses the role of artificial intelligence in shaping the industry. Furthermore, it highlights the ...

Read more

Treating cancer when neither chemotherapy nor transplant works

by Fundació Bancària 'la Caixa'

A clinical trial of CAR-T therapies has brought the word curable almost within touching distance for multiple myeloma, the second most common blood cancer in the world, thus increasing hope and qualit...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Identifican nuevos mecanismos implicados...

by CIMA - Centro de Investigación Médica Aplicada

Investigadores del Cima y de la Clínica Universidad de Navarra confir...

Photos Stream